Clinical Trial Update: Alvocidib, Cytarabine, and Mitoxantrone in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating alvocidib with cytarabine and mitoxantrone in newly diagnosed acute myeloid leukemia has completed. Results were posted on 2013-02-11.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Alvocidib (Flavopiridol)
• CYTARABINE (CYTARABINE)
• Mitoxantrone (mitoxantrone)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Adult Acute Basophilic Leukemia, Adult Acute Eosinophilic Leukemia | Phase 2 | Status: COMPLETED | Results posted: 2013-02-11